In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

Doctors and researchers at the University of Nebraska Medical Center are hoping to bring a different therapy that uses a ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

What are NGTs, how do they differ from GMOs and how are they agriculturally applied and regulated in the EU?View on euronews ...

In food crops, methods that introduce genes for desirable traits from other species have seen more opposition than techniques ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

The latest trends in cell therapies indicate a growing confidence in their effectiveness, an expansion of applications beyond ...

Do you think you could live alongside dodos and woolly mammoths? Colossal Biosciences thinks you can. The biotech company, which claims it recently resurrected the dire wolf, focuses on “de-extinction ...